This article summarized the industry viewpoints including the results of China 2020 medical insurance negotiations, TDDS, companies news of Innovent Biologics, Hengrui, Chi-Med and market review.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.